Messages in brief
Information on reporting according to the Antibiotics Quantitative Flows Regulation
Information on user registration and submission of sales and delivery notifications as well as ways to contact us can be found here.
Please note the…
Successful action against illegal cell therapies
Stem cell and other cell therapies are associated with great hopes, both among physicians and patients. Great progress is expected, especially in the…
Clinical research: Strengthening the research location with Pilot
EU Regulation 536/2014 is expected to standardize the approval procedure for clinical trials throughout the EU from fall 2018. These are an essential…
AGES launches social media campaign to report adverse reactions
AGES Medical Market Surveillance launches a social media campaign from November 7 - 11, 2016 to increase willingness to report adverse reactions.
Vie…
Review of the web presence of mail order pharmacies 2016
Legal trade in pharmaceutical specialties via the Internet was made possible in Austria in 2015 by an amendment to the Austrian Medicines Act and…
Measures for the safe use of Keppra 100mg/ml Oral Solution
Several cases of accidental overdose associated with Levetiracetam - Oral Solution have been reported throughout Europe. The majority of cases…
Project start VAC2VAC
VAC2VAC (Vaccine batch to vaccine batch comparison by consistency testing) is a research and development project in which new, innovative tests for…
PSUR submissions exclusively via central platform
Changed account data (BIC change)
Please note the changed BIC for transfers to the accounts of the Federal Office for Safety in Health Care (BASG) / AGES Medizinmarktaufsicht. (The…
PSUR repository mandatory in force as of June 13
Due to legal requirements (Reg. (EC) 726/2004, Article 25a), EMA is obliged to set up a database for periodic safety update reports (PSUR) and the…
